Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Blackpink's solo journeys: Complementary paths, not competition
-
4
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
5
Seoul to host winter festival from Dec. 13
-
6
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
7
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
8
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
9
Main opposition pushes to ease, not postpone, tax on crypto gains
-
10
Actor Song Joong-ki welcomes second child in Rome
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
[DISCLOSURE] GNCO (065060) said on Sept. 7 that it will invest 3.62 billion won (US$3.31 million) in its subsidiary Sumagen by issuing 786,654 stocks to fund its clinical investigation for AIDS vaccine development.
The amount is equivalent to 2.59 percent of the company’s equity capital.
After the acquisition on Sept. 8, GNCO’s stake in the company will rise to 35.22 percent.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The amount is equivalent to 2.59 percent of the company’s equity capital.
After the acquisition on Sept. 8, GNCO’s stake in the company will rise to 35.22 percent.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
![[Today’s K-pop] Babymonster logs 100m views with ‘Drip’ music video](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/22/20241122050051_0.jpg&u=20241122172213)